|
業務類別
|
Biotechnology |
|
業務概覽
|
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell. |
| 公司地址
| 455 East Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598 |
| 電話號碼
| +1 281 671-5150 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.fibrobiologics.com |
| 員工數量
| 15 |
| Dr. Hamid Khoja, PhD |
Chief Scientific Officer |
美元 325.00K |
23/04/2025 |
| Mr. Jason Davis |
Chief Financial Officer and Principal Accounting Officer |
-- |
24/02/2026 |
| Mr. Ruben A. Garcia |
General Counsel |
美元 270.83K |
23/04/2025 |
| Mr. Peter O’Heeron |
Chairperson of the Board and Chief Executive Officer |
美元 600.00K |
24/02/2026 |
|
|
| Mr. Richard C. Cilento, Jr,M.B.A. |
Independent Director |
24/02/2026 |
| Dr. Victoria Niklas, M.D. |
Independent Director |
24/02/2026 |
| Mr. Robert E. Hoffman, C.P.A. |
Director |
24/02/2026 |
| Ms. Stacy Ann Coen, M.B.A. |
Independent Director |
24/02/2026 |
| Mr. Matthew Link |
Independent Director |
24/02/2026 |
| Mr. Peter O’Heeron |
Chairperson of the Board and Chief Executive Officer |
24/02/2026 |
|
|
|
|
